These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 7912978)

  • 61. [Expression of p53 in gallbladder carcinoma and in dysplastic and metaplastic lesions of the surrounding mucosa].
    Billo P; Marchegiani C; Capella C; Sessa F
    Pathologica; 2000 Aug; 92(4):249-56. PubMed ID: 11029885
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Predictive survival markers in patients with surgically resected non-small cell lung carcinoma.
    Moldvay J; Scheid P; Wild P; Nabil K; Siat J; Borrelly J; Marie B; Farré G; Labib T; Pottier G; Sesboüé R; Bronner C; Vignaud JM; Martinet Y; Martinet N
    Clin Cancer Res; 2000 Mar; 6(3):1125-34. PubMed ID: 10741743
    [TBL] [Abstract][Full Text] [Related]  

  • 63. P-glycoprotein, HER-2/neu, and mutant p53 expression in human gynecologic tumors.
    Schneider J; Rubio MP; Barbazán MJ; Rodriguez-Escudero FJ; Seizinger BR; Castresana JS
    J Natl Cancer Inst; 1994 Jun; 86(11):850-5. PubMed ID: 7910219
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Increased expression of S100A6 (Calcyclin), a calcium-binding protein of the S100 family, in human colorectal adenocarcinomas.
    Komatsu K; Andoh A; Ishiguro S; Suzuki N; Hunai H; Kobune-Fujiwara Y; Kameyama M; Miyoshi J; Akedo H; Nakamura H
    Clin Cancer Res; 2000 Jan; 6(1):172-7. PubMed ID: 10656447
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Immunohistochemical detection of ras p21 oncoprotein in undifferentiated and well-differentiated epithelial carcinomas of the human ovary.
    Kuwashima Y; Shisa H; Uehara T; Kurosumi M; Kobayashi Y; Tanuma J; Shiromizu K; Matsuzawa M; Kishi K
    Anticancer Res; 1995; 15(6B):2847-50. PubMed ID: 8669877
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Dukes B colorectal cancer: distinct genetic categories and clinical outcome based on proximal or distal tumor location.
    Gervaz P; Bouzourene H; Cerottini JP; Chaubert P; Benhattar J; Secic M; Wexner S; Givel JC; Belin B
    Dis Colon Rectum; 2001 Mar; 44(3):364-72; discussion 372-3. PubMed ID: 11289282
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Clinicopathological and molecular biological studies of gastric adenomas with special reference to p53 abnormality.
    Sakurai S; Sano T; Nakajima T
    Pathol Int; 1995 Jan; 45(1):51-7. PubMed ID: 7704244
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The role of p53, MDM2 and c-erb B-2 oncoproteins, epidermal growth factor receptor and proliferation markers in the prognosis of urinary bladder cancer.
    Korkolopoulou P; Christodoulou P; Kapralos P; Exarchakos M; Bisbiroula A; Hadjiyannakis M; Georgountzos C; Thomas-Tsagli E
    Pathol Res Pract; 1997; 193(11-12):767-75. PubMed ID: 9521509
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Ras p21 expression in relation to histopathological variables and prognosis in colorectal adenocarcinoma.
    Sun XF; Hatschek T; Wingren S; Stål O; Carstensen JM; Zhang H; Boeryd B; Sjödahl R; Nordenskjöld B
    Acta Oncol; 1991; 30(8):933-9. PubMed ID: 1777245
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Expression and significance of oncoprotein p53, rasp21 and p185 in carcinomas and polyps of the large intestine].
    Wang J; Ni CR
    Zhonghua Bing Li Xue Za Zhi; 1994 Apr; 23(2):97-9. PubMed ID: 7915970
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Evidence of reciprocity of bcl-2 and p53 expression in human colorectal adenomas and carcinomas.
    Watson AJ; Merritt AJ; Jones LS; Askew JN; Anderson E; Becciolini A; Balzi M; Potten CS; Hickman JA
    Br J Cancer; 1996 Apr; 73(8):889-95. PubMed ID: 8611422
    [TBL] [Abstract][Full Text] [Related]  

  • 72. ras p21 oncoprotein expression in human colonic neoplasia--an immunohistochemical study with monoclonal antibody RAP-5.
    Lanza G
    Histopathology; 1988 Jun; 12(6):595-609. PubMed ID: 3047043
    [TBL] [Abstract][Full Text] [Related]  

  • 73. pS2 immunostaining of colorectal carcinoma.
    Shousha S; Luqmani YA; Sannino P; Rio MC; Coombes RC; Theodorou NA
    Mod Pathol; 1993 Jul; 6(4):446-8. PubMed ID: 8415590
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Invasion of the bladder by transitional cell carcinoma: its relation to histologic grade and expression of p53, MIB-1, c-erb B-2, epidermal growth factor receptor, and bcl-2.
    Vollmer RT; Humphrey PA; Swanson PE; Wick MR; Hudson ML
    Cancer; 1998 Feb; 82(4):715-23. PubMed ID: 9477105
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Immunohistochemical study of growth factors and oncogenes in gastric carcinomas].
    Yamagiwa H; Onishi N; Onishi T; Onishi T; Onishi H; Satomoto K; Watanabe K; Nishii M
    Rinsho Byori; 1993 Jul; 41(7):795-9. PubMed ID: 8103127
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Immunohistochemical assay for detection of K-ras protein expression in metastatic colorectal cancer.
    Elsabah MT; Adel I
    J Egypt Natl Canc Inst; 2013 Mar; 25(1):51-6. PubMed ID: 23499207
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The immunohistochemical expressions of epidermal growth factors, epidermal growth factor receptors and c-erbB-2 oncoprotein in human pancreatic cancer.
    Yamanaka Y
    Nihon Ika Daigaku Zasshi; 1992 Feb; 59(1):51-61. PubMed ID: 1347773
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Immunohistochemical detection of p21waf1/cip1/sdi1 and p53 proteins in formalin-fixed, paraffin-embedded tissue sections of colorectal carcinoma.
    Sasaki K; Sato T; Kurose A; Ikeda E
    Hum Pathol; 1996 Sep; 27(9):912-6. PubMed ID: 8816885
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Growth factors and oncogene products in transitional cell carcinoma.
    Nakanishi K; Kawai T; Suzuki M; Torikata C
    Mod Pathol; 1996 Mar; 9(3):292-7. PubMed ID: 8685230
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Clinicopathologic and immunohistochemical study of small apparently "de novo" colorectal adenocarcinomas.
    Hornick JL; Farraye FA; Odze RD
    Am J Surg Pathol; 2007 Feb; 31(2):207-15. PubMed ID: 17255765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.